On the contrary, highly metastatic lung adenocarcinomas exhibit decreased SETDB1 activity [75], suggesting that SETDB1 may act as a key oncogene only in the initial stages of NSCLC. The gene discussed is SETDB1; the disease is non-small cell lung carcinoma.